메뉴 건너뛰기




Volumn 22, Issue 12, 2008, Pages 1514-1516

Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT;

EID: 56549091690     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02693.x     Document Type: Letter
Times cited : (13)

References (6)
  • 2
    • 4644274040 scopus 로고    scopus 로고
    • Etanercept therapy for patients with psoriasic arthritis and concurrent hepatitis C virus infection. report of 3 cases
    • Magliocco MA, Gottlieb AB. Etanercept therapy for patients with psoriasic arthritis and concurrent hepatitis C virus infection. report of 3 cases. J Am Acad Dermatol 2004 51 : 580 584.
    • (2004) J Am Acad Dermatol , vol.51 , pp. 580-584
    • Magliocco, M.A.1    Gottlieb, A.B.2
  • 3
    • 33845585614 scopus 로고    scopus 로고
    • Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus
    • Marotte H, Fontanges E, Bailly F, Zoulim F, Trepo C, Miossec P. Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus. Rheumatology (Oxford) 2007 46 : 97 99.
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 97-99
    • Marotte, H.1    Fontanges, E.2    Bailly, F.3    Zoulim, F.4    Trepo, C.5    Miossec, P.6
  • 4
    • 0344873641 scopus 로고    scopus 로고
    • Etanercept therapy in patients with autoimmunity and hepatitis C
    • Khanna M, Shirodkar MA, Gottlieb AB. Etanercept therapy in patients with autoimmunity and hepatitis C. J Dermatolog Treat 2003 14 : 229 232.
    • (2003) J Dermatolog Treat , vol.14 , pp. 229-232
    • Khanna, M.1    Shirodkar, M.A.2    Gottlieb, A.B.3
  • 5
    • 13844294333 scopus 로고    scopus 로고
    • Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naïve patients with chronic hepatitis C virus infection: A phase 2 randomized, double-blind, placebo-controlled study
    • Zein NN. Etanercept Study Group. Etanercept as an adjuvant to interferon and ribavirin in treatment-naïve patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol 2005 42 : 315 322.
    • (2005) J Hepatol , vol.42 , pp. 315-322
    • Zein, N.N.1
  • 6
    • 31344434720 scopus 로고    scopus 로고
    • Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis and concomitant hepatitis C infection
    • Rokhsar C, Rabhan N, Cohen SR. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis and concomitant hepatitis C infection. J Am Acad Dermatol 2006 54 : 361 362.
    • (2006) J Am Acad Dermatol , vol.54 , pp. 361-362
    • Rokhsar, C.1    Rabhan, N.2    Cohen, S.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.